Summary
This Nature Reviews article synthesises multiomics approaches to elucidate the molecular risk factors and biological pathways underlying inflammatory bowel disease. As suggested by the title and journal scope, the authors integrate findings across genomics, transcriptomics, metabolomics and proteomics to characterise IBD aetiology, with potential implications for stratification and intervention. The review reflects the growing recognition (as of 2022) that integrative molecular profiling may reveal disease mechanisms inaccessible to single-omic approaches.
Regional applicability
IBD is a significant public health burden in the United Kingdom, with epidemiological and clinical relevance to UK gastroenterology and primary care. The multiomics framework reviewed here is applicable to UK research infrastructure and precision medicine initiatives, though the paper does not report UK-specific epidemiology or health system implementation.
Key measures
Molecular signatures across genomic, transcriptomic, metabolomic and proteomic data; IBD risk factor identification; pathway annotation
Outcomes reported
The study synthesises multiomics (genomics, transcriptomics, metabolomics, proteomics) evidence to characterise inflammatory bowel disease risk factors and biological pathways. It reviews integrative approaches to understanding IBD pathogenesis across multiple molecular levels.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.